Variant report
Variant | nsv522208 |
---|---|
Chromosome Location | chr4:92241587-92283771 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:134)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr4:92279590-92279870 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr4:92246684-92246980 | GM12878 | blood: | n/a | n/a |
3 | BATF | chr4:92246616-92246958 | GM12878 | blood: | n/a | n/a |
4 | BATF | chr4:92279593-92279805 | GM12878 | blood: | n/a | n/a |
5 | BATF | chr4:92280369-92280568 | GM12878 | blood: | n/a | n/a |
6 | BCL11A | chr4:92279611-92279846 | GM12878 | blood: | n/a | n/a |
7 | BHLHE40 | chr4:92264987-92264999 | GM12878 | blood: | n/a | n/a |
8 | CEBPB | chr4:92272244-92272571 | IMR90 | lung: | n/a | chr4:92272388-92272399 chr4:92272386-92272399 chr4:92272386-92272397 chr4:92272388-92272397 |
9 | CEBPB | chr4:92258443-92258660 | HepG2 | liver: | n/a | n/a |
10 | CEBPB | chr4:92272267-92272556 | HepG2 | liver: | n/a | chr4:92272388-92272399 chr4:92272386-92272399 chr4:92272386-92272397 chr4:92272388-92272397 |
11 | CEBPB | chr4:92272250-92272485 | K562 | blood: | n/a | chr4:92272388-92272399 chr4:92272386-92272399 chr4:92272386-92272397 chr4:92272388-92272397 |
12 | CEBPB | chr4:92260282-92260576 | HepG2 | liver: | n/a | chr4:92260436-92260447 |
13 | CHD2 | chr4:92258506-92258507 | GM12878 | blood: | n/a | n/a |
14 | CTCF | chr4:92247623-92247698 | GM13976 | blood: | n/a | n/a |
15 | CTCF | chr4:92280494-92280526 | Kidney_OC | kidney: | n/a | n/a |
16 | CTCF | chr4:92263350-92263410 | Medullo | brain: | n/a | n/a |
17 | CTCF | chr4:92278078-92278131 | Kidney_OC | kidney: | n/a | n/a |
18 | CTCF | chr4:92247480-92247630 | GM12874 | blood: | n/a | n/a |
19 | CTCF | chr4:92271120-92271270 | AoAF | blood vessel: | n/a | n/a |
20 | E2F4 | chr4:92259567-92259767 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | E2F4 | chr4:92274005-92274091 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | EBF1 | chr4:92254085-92254285 | GM12878 | blood: | n/a | chr4:92254154-92254165 |
23 | EBF1 | chr4:92283345-92283373 | GM12878 | blood: | n/a | n/a |
24 | EBF1 | chr4:92279631-92279782 | GM12878 | blood: | n/a | n/a |
25 | EBF1 | chr4:92279638-92279924 | GM12878 | blood: | n/a | n/a |
26 | EBF1 | chr4:92269540-92269661 | GM12878 | blood: | n/a | n/a |
27 | EBF1 | chr4:92266985-92267004 | GM12878 | blood: | n/a | n/a |
28 | EP300 | chr4:92258670-92258840 | GM12878 | blood: | n/a | chr4:92258752-92258766 |
29 | EP300 | chr4:92246620-92246949 | SK-N-SH_RA | brain: | n/a | chr4:92246898-92246912 |
30 | EP300 | chr4:92280162-92280549 | GM12878 | blood: | n/a | n/a |
31 | EP300 | chr4:92246505-92247133 | SK-N-SH | brain: | n/a | chr4:92246526-92246533 chr4:92246898-92246912 |
32 | EP300 | chr4:92246540-92246754 | SK-N-SH_RA | brain: | n/a | n/a |
33 | EP300 | chr4:92280538-92280725 | GM12878 | blood: | n/a | n/a |
34 | ESR1 | chr4:92246589-92246957 | ECC-1 | luminal epithelium: | n/a | n/a |
35 | FOS | chr4:92246676-92247017 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | FOS | chr4:92251930-92252285 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | FOS | chr4:92246734-92247049 | HUVEC | blood vessel: | n/a | n/a |
38 | FOS | chr4:92246671-92247017 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | FOS | chr4:92251940-92252272 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | FOS | chr4:92246689-92247009 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | FOS | chr4:92246688-92246996 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | FOS | chr4:92251930-92252300 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | FOSL2 | chr4:92246687-92247125 | SK-N-SH | brain: | n/a | n/a |
44 | FOSL2 | chr4:92251826-92252389 | SK-N-SH | brain: | n/a | n/a |
45 | GATA3 | chr4:92258710-92259254 | SK-N-SH | brain: | n/a | chr4:92259012-92259028 |
46 | GATA3 | chr4:92241765-92242135 | MCF-7 | breast: | n/a | chr4:92241934-92241941 chr4:92241927-92241948 chr4:92241933-92241943 chr4:92241934-92241941 chr4:92241930-92241946 chr4:92241934-92241941 |
47 | GATA3 | chr4:92241781-92242096 | T-47D | breast: | n/a | chr4:92241934-92241941 chr4:92241927-92241948 chr4:92241933-92241943 chr4:92241934-92241941 chr4:92241930-92241946 chr4:92241934-92241941 |
48 | GATA3 | chr4:92258717-92259340 | SK-N-SH | brain: | n/a | chr4:92259012-92259028 |
49 | GATA3 | chr4:92246366-92247212 | SK-N-SH | brain: | n/a | n/a |
50 | GATA3 | chr4:92264822-92264999 | SH-SY5Y | brain: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:92228930..92230474-chr4:92239556..92242007,2 | K562 | blood: | |
2 | chr4:92249209..92252138-chr4:92252795..92255607,2 | MCF-7 | breast: | |
3 | chr4:92256031..92258951-chr4:92265643..92267671,2 | MCF-7 | breast: | |
4 | chr4:92256031..92258951-chr4:92265643..92267671,2 | MCF-7 | breast: | |
5 | chr4:92249209..92252138-chr4:92252795..92255607,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000249049 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1528580 | chr4:92241587-92241588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554362411 | chr4:92241621-92241622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs34853891 | chr4:92241624-92241625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543015503 | chr4:92241642-92241643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs576674649 | chr4:92241668-92241669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs545334141 | chr4:92241684-92241685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565490237 | chr4:92241774-92241775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572647116 | chr4:92241780-92241781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs542271658 | chr4:92246206-92246207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs561957576 | chr4:92246207-92246208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191533881 | chr4:92246214-92246215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs181224160 | chr4:92246335-92246336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371255259 | chr4:92246340-92246341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs3762827 | chr4:92246344-92246345 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs185335662 | chr4:92246367-92246368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566683311 | chr4:92246396-92246397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190590693 | chr4:92246441-92246442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs367597047 | chr4:92246442-92246443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182726242 | chr4:92246504-92246505 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs116294821 | chr4:92246522-92246523 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs1528572 | chr4:92246541-92246542 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs3762829 | chr4:92246547-92246548 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs187800901 | chr4:92246577-92246578 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs145771843 | chr4:92246605-92246606 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs1528573 | chr4:92246681-92246682 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs1528574 | chr4:92246693-92246694 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs541639216 | chr4:92246706-92246707 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs548396852 | chr4:92246711-92246712 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs1528575 | chr4:92246811-92246812 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs191942507 | chr4:92246821-92246822 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs116072522 | chr4:92246884-92246885 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs35664066 | chr4:92246897-92246898 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs564094223 | chr4:92246967-92246968 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs549463415 | chr4:92246977-92246978 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs533455376 | chr4:92246993-92246994 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs1528576 | chr4:92247051-92247052 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs1528577 | chr4:92247095-92247096 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs140624423 | chr4:92247119-92247120 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs10718334 | chr4:92247138-92247139 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs1528578 | chr4:92247173-92247174 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs536420824 | chr4:92247230-92247231 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs2178222 | chr4:92247337-92247338 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs145682148 | chr4:92247357-92247358 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs138256643 | chr4:92247368-92247369 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs552887465 | chr4:92247369-92247370 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs1969532 | chr4:92247487-92247488 | ZNF genes & repeats | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs539768488 | chr4:92247537-92247538 | ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs376841461 | chr4:92247542-92247543 | ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs142760661 | chr4:92247607-92247608 | ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs143394817 | chr4:92247615-92247616 | ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:92241200-92241800 | Enhancers | Brain Germinal Matrix | brain |
2 | chr4:92246200-92246800 | Enhancers | NH-A | brain |
3 | chr4:92246200-92247000 | Enhancers | HUVEC | blood vessel |
4 | chr4:92247400-92248600 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
5 | chr4:92247800-92248800 | ZNF genes & repeats | Fetal Intestine Small | intestine |
6 | chr4:92247800-92249200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr4:92248000-92248400 | ZNF genes & repeats | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr4:92248000-92248400 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
9 | chr4:92248000-92248400 | ZNF genes & repeats | HUES64 Cell Line | embryonic stem cell |
10 | chr4:92248000-92248600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr4:92248600-92249000 | ZNF genes & repeats | iPS-15b Cell Line | embryonic stem cell |
12 | chr4:92251800-92252200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr4:92252000-92252400 | Enhancers | NH-A | brain |
14 | chr4:92276400-92279800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr4:92279800-92280200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
16 | chr4:92279800-92280200 | Enhancers | Pancreas | Pancrea |
17 | chr4:92279800-92281000 | Enhancers | Rectal Mucosa Donor 31 | rectum |